Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online August 23, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0483v1
25/12/3121    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pruitt, S. C.
Right arrow Articles by Freeland, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pruitt, S. C.
Right arrow Articles by Freeland, A.
Submitted on June 19, 2007
Accepted on August 16, 2007

TISSUE-SPECIFIC STEM CELLS

Reduced Mcm2 Expression Results in Severe Stem/Progenitor Cell Deficiency and Cancer

Steven C. Pruitt 1*, Kimberly J. Bailey 1, Amy Freeland 1

1 Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York, 14263, USA

* To whom correspondence should be addressed. E-mail: steven.pruitt{at}roswellpark.org.


   Abstract

Mcm2 is a component of the DNA replication licensing complex which marks DNA replication origins during G1 of the cell cycle for use in the subsequent S-phase. It is expressed in stem/progenitor cells in a variety of regenerative tissues in mammals. Here, we have utilized the Mcm2 gene to develop a transgenic mouse in which somatic stem/progenitor cells can be genetically modified in the adult. In these mice a tamoxifen inducible form of Cre-recombinase is integrated 3' to the Mcm2 coding sequence and expressed via an internal ribosome entry site (IRES). Heterozygous Mcm2IRES-CreERT2/wt mice are phenotypically indistinguishable from wild type at least through one year of age. In bigenic Mcm2IRES-CreERT2/wt; Z/EG reporter mice, tamoxifen dependent EGFP expression is inducible in a wide variety of somatic stem cells and their progeny. However, in Mcm2IRES-CreERT2/IRES-CreERT2 homozygous embryos or MEFs, Mcm2 is reduced to approximately a third of wild type levels. Despite the fact that these mice develop normally and are asymptomatic as young adults, lifespan is greatly reduced with most surviving to only ~10-12 weeks of age. They demonstrate severe deficiencies in the proliferative cell compartments of a variety of tissues, including the sub-ventricular zone of the brain, muscle, and intestinal crypts. However the immediate cause of death in most of these animals is cancer where the majority develop lymphomas. These studies directly demonstrate that deficiencies in the function of the core DNA replication machinery which are compatible with development and survival nonetheless result in a chronic phenotype leading to stem cell deficiency in multiple tissues and cancer.

Key Words. Somatic stem cells, Cellular proliferation, Cre-loxP system, Neural stem cell, Muscle stem cells, Intestinal crypt stem cell, DNA Replication Licensing Factor




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Ibarra, E. Schwob, and J. Mendez
Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication
PNAS, July 1, 2008; 105(26): 8956 - 8961.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.